Stereotactic Ablative Radiotherapy in... - Advanced Prostate...

Advanced Prostate Cancer

22,373 members28,135 posts

Stereotactic Ablative Radiotherapy in Oligometastatic Disease, new retrospectice study

Maxone73 profile image
4 Replies

"The most common primary malignancy types were prostate (n = 14), colorectal (n = 10), lung (n = 7), and breast cancers (n = 6). The median follow-up was 30 months, ranging from 9 to 79. The 1-, 3-, and 5-year PFS and OS rates were 54.9%, 37.0%, and 37.0% and 98.3%, 84.4%, and 73.8%, respectively, and the median time to first progression was 15 (range, 2-32) months. Twenty-four (40%) patients had no recurrence. In our analysis, primary tumor site was not an independent prognostic factor. "

ascopubs.org/doi/10.1200/GO...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Jewelrylady profile image
Jewelrylady

interesting study, but only 3 prostate cancer patients, and authors note results may be worse with a larger PC population.

Maxone73 profile image
Maxone73 in reply toJewelrylady

thought they were 14??

Jewelrylady profile image
Jewelrylady in reply toMaxone73

Sorry, it did say 14 patients. Not sure where I got 3, but here is what it said about the 14. Hopefully there are more studies that can validate the 100% survival rate for men with only bone metastasis. Thank you for sharing the article. I found it hopeful.

“In addition, we analyzed the relationship between the primary tumor site and OS/PFS (Figs 2 and 3). There was no correlation observed in a pairwise comparison of all primary tumor sites (the P value was >.05). The smaller number of patients in our cohort might also have influenced this outcome. We have noted some differences in OS in patients with prostate cancer (P = .073), which had a 100% OS rate. We suppose that this is primarily because the prostate cancers in our study had only bone metastases because of early detection of metastases. We assume that if we had more patients with prostate cancer with metastases to other sites, the OS rates would be worse.”

j-o-h-n profile image
j-o-h-n

Title: Stereotactic Ablative Radiotherapy in Oligometastatic Disease, new retrospectice study.

I started whispering this title to my blow up doll and she winked at me. What the hell do you think she means/wants?

Good Luck, Good Health and Good Humor.

j-o-h-n

Not what you're looking for?

You may also like...

Radiotherapy & Oligometastatic PCa at Johns Hopkins

New study [1]. "This study analyzed 156 OPCa {oligometastatic prostate cancer} patients and 354...
pjoshea13 profile image

Radiotherapy in the Definitive Management of Oligometastatic Prostate Cancer

"TAKE-HOME MESSAGE The authors of this retrospective study from a single tertiary care institution...
snoraste profile image

Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via PSMA pet scan

" 31.9% were bio-chemically Disease Free (bDFS) at 15 mo. ! ! ! ! ! All patients with...
George71 profile image

"Early initiation of Lu-177 PSMA radioligand therapy prolongs overall survival in metastatic prostate cancer"

Lu 177 PSMA was effective in prolonging life when used earlier in the disease process....
tango65 profile image

Stereotactic Ablative Radiotherapy for Management of Spinal Metastases

TAKE-HOME MESSAGE Spinal metastases are a source of significant pain and morbidity, especially in...
TNCanuck profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.